The Food and Drug Administration (FDA) has announced an extension of the comment period for a Request for Information regarding gluten-free labeling and the prevention of cross-contact with gluten in packaged foods. Comments can be submitted electronically or in writing until April 22, 2026.
Read More
Approximately 3 million individuals in the United States are affected by celiac disease, a condition where gluten triggers the production of antibodies that damage the small intestine lining. This damage restricts nutrient absorption and increases the risk of serious health issues, including nutritional deficiencies, osteoporosis, slow growth, infertility, miscarriages, and intestinal cancers.
On August 2, 2013, the FDA issued a final rule that defined “gluten-free” for labeling purposes, providing consumers with assurance that products labeled as such meet specific standards for gluten content. The label is voluntary, allowing manufacturers to use it if they comply with regulatory requirements.
On August 12, 2020, the FDA also released a final rule addressing gluten-free labeling for fermented or hydrolyzed foods, which includes products like yogurt, sauerkraut, pickles, cheese, and certain FDA-regulated alcoholic beverages. This rule, while not altering the definition of “gluten-free,” sets compliance standards for these specific food categories and outlines how the FDA will verify compliance for distilled products such as vinegar.